Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2026-07-15
VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR HBM7575 FOR ASTHMA BY THE NMPA
2026-07-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026
2026-06-25
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 JUNE 2026
2026-06-15
VOLUNTARY ANNOUNCEMENT - JOINTLY INITIATE MEGASTREAM TECHBIO WITH BIOMAP
2026-06-15
VOLUNTARY ANNOUNCEMENT - JURY VERDICT IN U.S. PATENT INFRINGEMENT LITIGATION
2026-06-10
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF IND APPLICATION FOR HBM7004 FOR THE TREATMENT OF ADVANCED SOLID TUMORS
2026-06-09
VOLUNTARY ANNOUNCEMENT - FIRST PATIENTS DOSED IN PHASE II SIRIUS COPD STUDY OF HBM9378/WIN378, A FULLY HUMAN ULTRA LONG-ACTING ANTI-TSLP ANTIBODY
2026-06-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
2026-05-21
Next Day Disclosure Return
2026-05-20
Next Day Disclosure Return
2026-05-19
Next Day Disclosure Return
2026-05-18
Next Day Disclosure Return
2026-05-18
VOLUNTARY ANNOUNCEMENT - RELEASE OF PRECLINICAL DATA FOR LET003, FIRST AI-ENABLED DRUG CANDIDATE, A NEXT-GENERATION ACVR2A/2B-TARGETING ANTIBODY FOR OBESITY TREATMENT
2026-05-15
Next Day Disclosure Return
2026-05-14
Next Day Disclosure Return
2026-05-13
Next Day Disclosure Return
2026-05-13
INSIDE INFORMATION - INVESTIGATION AGAINST AN INDEPENDENT NON-EXECUTIVE DIRECTOR
2026-05-12
Next Day Disclosure Return
2026-05-11
Next Day Disclosure Return
2026-05-08
Next Day Disclosure Return
1
2
···
21
Jump